from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0801/-

LFCtreatmentdescriptionclass of inhibitor

-0.319

Amikacinug/mL Amikacintranslation

-0.285

Cap5-10ug/mL Capreomycintranslation

-0.268

Rox10-50 ug/mL Roxithromycintranslation

-0.009

SM2-5 ug/mL Streptomycintranslation

-1.408

Tet5-10 ug/mL Tetracyclinetranslation

0.386

Rif0.2-5ug/mL Rifampicintranscription

0.517

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.959

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.458

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.554

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.479

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.160

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.062

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.653

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.226

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.214

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.022

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.069

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.943

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.764

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.411

KCN5-20 ug/mL Potassium cyaniderespiration

0.871

NaN30.2-2 mM Sodium aziderespiration

0.227

Nigericin50 uM Nigericinrespiration

0.175

TRC10-150 ug/mL Triclosanrespiration

-0.319

TRZ10-25 ug/mL Thioridazinerespiration

-1.691

Valinomycin0.5-10 uM Valinomycinrespiration

5.697

ZnSO42 mM ZnSO4respiration

-0.426

menadione6-10 ug/mL Menadionerespiration

0.353

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.521

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.133

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.611

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.207

NRP_1Non-replicating persistence stage 1dosRassociated

-0.108

Amp0.2mg/mL AmpicillincellWall

0.217

Cephalexin20-100 ug/mL CephalexincellWall

-0.064

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.558

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.092

EMB10-20 ug/mL EthambutolcellWall

0.192

Eta12-40 ug/mL EthionamidecellWall

0.004

INH0.2-0.4 ug/mL IsoniazidcellWall

0.193

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.137

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.600

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.232

BZA0.12 mg/mL BenzamidearomaticAmides

0.100

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.010

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.380

H2O24 mM hydrogen peroxideDNAdamaging

0.566

Levo10 ug/mL LevofloxacinDNAdamaging

-0.263

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.587

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.488

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.196

UVUV-irradiationDNAdamaging

-0.870

ARP41-4 ug/mL Antitubercular compound ARP4?

0.341

Antimycin12.5-50 ug/mL Antimycin A?

0.320

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.112

PA_110-50 ug/mL Antitubercular compound PA-1?

0.316

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.453

PA8240.2-2 ug/mL PA-824?

-0.669

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.282

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.334

Verapamil50 uM Verapamil?

0.874

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.607

methoxatin10-20 ug/mL Methoxatin?